These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32015046)

  • 1. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
    Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
    Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.
    McPhee JB; Lewenza S; Hancock RE
    Mol Microbiol; 2003 Oct; 50(1):205-17. PubMed ID: 14507375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
    Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
    Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of Norspermidine Contributes to Aminoglycoside Resistance in
    Bolard A; Schniederjans M; Haüssler S; Triponney P; Valot B; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Schurek KN; Sampaio JL; Kiffer CR; Sinto S; Mendes CM; Hancock RE
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4345-51. PubMed ID: 19635950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.
    Poole K; Lau CH; Gilmour C; Hao Y; Lam JS
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7276-89. PubMed ID: 26369970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
    Barrow K; Kwon DH
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
    Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
    Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Activity of the Novel Antimicrobial Peptide Dendrimer G3KL against Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Pires J; Siriwardena TN; Stach M; Tinguely R; Kasraian S; Luzzaro F; Leib SL; Darbre T; Reymond JL; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7915-8. PubMed ID: 26459893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas aeruginosa PAO1.
    Kwon DH; Lu CD
    Antimicrob Agents Chemother; 2006 May; 50(5):1615-22. PubMed ID: 16641426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.
    Macfarlane ELA; Kwasnicka A; Hancock REW
    Microbiology (Reading); 2000 Oct; 146 ( Pt 10)():2543-2554. PubMed ID: 11021929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
    Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
    Lee JY; Ko KS
    Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of Metabolic and Lipid Profiles in Polymyxin-Resistant Pseudomonas aeruginosa.
    Han ML; Zhu Y; Creek DJ; Lin YW; Anderson D; Shen HH; Tsuji B; Gutu AD; Moskowitz SM; Velkov T; Li J
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide dendrimers G3KL and TNS18 inhibit Pseudomonas aeruginosa biofilms.
    Han X; Liu Y; Ma Y; Zhang M; He Z; Siriwardena TN; Xu H; Bai Y; Zhang X; Reymond JL; Qiao M
    Appl Microbiol Biotechnol; 2019 Jul; 103(14):5821-5830. PubMed ID: 31101943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
    Abraham N; Kwon DH
    FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB.
    Chung ES; Lee JY; Rhee JY; Ko KS
    J Med Microbiol; 2017 Jun; 66(6):833-841. PubMed ID: 28621641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.